Pyruvate kinase M2 and cancer: an updated assessment

被引：153
|
作者：
Iqbal, Mohd Askandar [1 ]
Gupta, Vibhor [1 ]
Gopinath, Prakasam [1 ]
Mazurek, Sybille [2 ]
Bamezai, Rameshwar N. K. [1 ]
机构：
[1] Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India
[2] Univ Giessen, Inst Vet Physiol & Biochem, D-35392 Giessen, Germany
来源：
FEBS LETTERS | 2014年 / 588卷 / 16期
关键词：
PKM2; Cancer metabolism; Warburg effect; POSITRON-EMISSION-TOMOGRAPHY; HYPOXIA-INDUCIBLE FACTOR-1; ISOENZYME TYPE M2; TUMOR-GROWTH; AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; COLORECTAL-CANCER; PROTEIN-KINASE; NUCLEAR TRANSLOCATION; GENE-TRANSCRIPTION;
D O I：
10.1016/j.febslet.2014.04.011
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Cancer cells are characterized by high glycolytic rates to support energy regeneration and anabolic metabolism, along with the expression of pyruvate kinase isoenzyme M2 (PKM2). The latter catalyzes the last step of glycolysis and reprograms the glycolytic flux to feed the special metabolic demands of proliferating cells. Besides, PKM2 has moonlight functions, such as gene transcription, favoring cancer. Accumulating evidence suggests a critical role played by the low-activity-dimeric PKM2 in tumor progression, supported by the identification of mutations which result in the down-regulation of its activity and tumorigenesis in a nude mouse model. This review discusses PKM2 regulation and the benefits it confers to cancer cells. Further, conflicting views on PKM2's role in cancer, its therapeutic relevance and future directions in the field are also discussed. (C) 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码：2685 / 2692
页数：8
相关论文
共 50 条
  • [21] Pyruvate kinase isoenzyme M2 is not of diagnostic relevance as a marker for oral cancer
    Ervens, Juergen
    Fuchs, Hendrik
    Nieniann, Volker-Till
    Hoffmeister, Bodo
    JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2008, 36 (02) : 89 - 94
  • [22] DIAGNOSTIC VALUE OF TUMOR M2 PYRUVATE KINASE IN PATIENTS WITH LUNG CANCER
    Aslankara, Asuman
    Ortakoylu, Mediha Gonenc
    Bahadir, Ayse
    Alkan, Figen
    Caglar, Emel
    Uzun, Hafize
    Korkmaz, Gulcan
    Urer, Halidenur
    RESPIROLOGY, 2013, 18 : 23 - 23
  • [23] Tumor pyruvate kinase M2:A promising molecular target of gastrointestinal cancer
    Chen Guo
    Guan Li
    Jianing Hou
    Xingming Deng
    Sheng Ao
    Zhuofei Li
    Guoqing Lyu
    Chinese Journal of Cancer Research, 2018, 30 (06) : 669 - 676
  • [24] Pyruvate Kinase M2: Multiple Faces for Conferring Benefits on Cancer Cells
    Tamada, Mayumi
    Suematsu, Makoto
    Saya, Hideyuki
    CLINICAL CANCER RESEARCH, 2012, 18 (20) : 5554 - 5561
  • [25] Identification of Natural Compounds as Inhibitors of Pyruvate Kinase M2 for Cancer Treatment
    Sarfraz, Iqra
    Rasul, Azhar
    Jabeen, Farhat
    Sultana, Tayyaba
    Adem, Sevki
    MOLECULES, 2022, 27 (20):
  • [26] Tumor pyruvate kinase M2: A promising molecular target of gastrointestinal cancer
    Guo, Chen
    Li, Guan
    Hou, Jianing
    Deng, Xingming
    Ao, Sheng
    Li, Zhuofei
    Lyu, Guoqing
    CHINESE JOURNAL OF CANCER RESEARCH, 2018, 30 (06) : 669 - 676
  • [27] Correlation of Pyruvate Kinase M2 Expression with Clinicopathological Data in Ovarian Cancer
    Kobierzycki, Christopher
    Piotrowska, Aleksandra
    Latkowski, Krzysztof
    Zabel, Maciej
    Nowak-Markwitz, Ewa
    Spaczynski, Marek
    Kedzia, Witold
    Pula, Bartosz
    Podhorska-Okolow, Marzenna
    Dziegiel, Piotr
    ANTICANCER RESEARCH, 2018, 38 (01) : 295 - 300
  • [28] Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer Phenotypes
    Apostolidi, Maria
    Vathiotis, Ioannis A.
    Muthusamy, Viswanathan
    Gaule, Patricia
    Gassaway, Brandon M.
    Rimm, David L.
    Rinehart, Jesse
    CANCER RESEARCH, 2021, 81 (16) : 4346 - 4359
  • [29] Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis
    Zahra, Kulsoom
    Dey, Tulika
    Ashish
    Mishra, Surendra Pratap
    Pandey, Uma
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [30] Allosteric regulation of human pyruvate kinase M2
    Yuan, M.
    Mcnae, I.
    Chen, Y.
    Yen, L.
    Ning, J.
    Morgan, H.
    Walkinshaw, M.
    FEBS JOURNAL, 2015, 282 : 326 - 326
12345